DE69115104T2 - Composition comprising at least two different antibodies or fragments thereof. - Google Patents

Composition comprising at least two different antibodies or fragments thereof.

Info

Publication number
DE69115104T2
DE69115104T2 DE69115104T DE69115104T DE69115104T2 DE 69115104 T2 DE69115104 T2 DE 69115104T2 DE 69115104 T DE69115104 T DE 69115104T DE 69115104 T DE69115104 T DE 69115104T DE 69115104 T2 DE69115104 T2 DE 69115104T2
Authority
DE
Germany
Prior art keywords
antibody
antibodies
fragment
binding
target site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69115104T
Other languages
German (de)
English (en)
Other versions
DE69115104D1 (de
Inventor
Thomas Stewart Beggs
Paul James Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan Nederland Services BV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26296814&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69115104(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB909006327A external-priority patent/GB9006327D0/en
Priority claimed from GB909021671A external-priority patent/GB9021671D0/en
Application filed by Unilever NV filed Critical Unilever NV
Application granted granted Critical
Publication of DE69115104D1 publication Critical patent/DE69115104D1/de
Publication of DE69115104T2 publication Critical patent/DE69115104T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6815—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
    • A61K47/6885—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy the conjugate or the polymer being a starburst, a dendrimer, a cascade
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/94—Involves covalent bonding to the substrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Detergent Compositions (AREA)
DE69115104T 1990-03-21 1991-03-20 Composition comprising at least two different antibodies or fragments thereof. Expired - Fee Related DE69115104T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909006327A GB9006327D0 (en) 1990-03-21 1990-03-21 Delivery of therapeutic agents
GB909021671A GB9021671D0 (en) 1990-10-05 1990-10-05 Delivery of agents

Publications (2)

Publication Number Publication Date
DE69115104D1 DE69115104D1 (de) 1996-01-18
DE69115104T2 true DE69115104T2 (de) 1996-05-15

Family

ID=26296814

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69115104T Expired - Fee Related DE69115104T2 (de) 1990-03-21 1991-03-20 Composition comprising at least two different antibodies or fragments thereof.

Country Status (9)

Country Link
EP (1) EP0453097B1 (https=)
JP (1) JP3098050B2 (https=)
AT (1) ATE131069T1 (https=)
AU (1) AU641736B2 (https=)
BR (1) BR9101117A (https=)
CA (1) CA2038578C (https=)
DE (1) DE69115104T2 (https=)
ES (1) ES2082132T3 (https=)
IN (1) IN172885B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1009834C2 (nl) * 1998-08-10 2000-02-11 Stanislaus Laurens Johan Woute Antistoffen voor toepassing in de gerichte en tijdelijke behandeling van mens en dier.
EP1212100B1 (en) * 1999-09-16 2005-04-06 Unilever Plc Delivery system for antidandruff agent
US7285264B2 (en) 2003-09-08 2007-10-23 E.I. Du Pont De Nemours And Company Peptide-based body surface coloring reagents
US7807141B2 (en) 2003-09-08 2010-10-05 E.I. Du Pont De Nemours And Company Peptide-based oral care surface reagents for personal care
US7220405B2 (en) * 2003-09-08 2007-05-22 E. I. Du Pont De Nemours And Company Peptide-based conditioners and colorants for hair, skin, and nails
US7585495B2 (en) 2003-09-08 2009-09-08 E. I. Du Pont De Nemours And Company Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom
US7736633B2 (en) 2005-09-28 2010-06-15 E.I. Du Pont De Nemours And Company Method for enhancing effects of colorants and conditioners
ES2606349T3 (es) 2008-06-13 2017-03-23 Oragenics, Inc. Uso de bacterias productoras de peróxido de hidrógeno para el blanqueamiento de los dientes
US8481678B2 (en) 2009-03-30 2013-07-09 E I Du Pont De Nemours And Company Peptide-based tooth whitening reagents
RU2660373C2 (ru) 2010-12-20 2018-07-05 Е.И.Дюпон Де Немур Энд Компани Ферментативное образование перкислоты для применения в продуктах для ухода за полостью рта

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1433593A (en) * 1972-06-09 1976-04-28 Royal College Of Surgeons Conjugates
EP0271180B2 (en) * 1986-08-18 1997-06-18 The Dow Chemical Company Starburst conjugates
US4943525A (en) * 1987-11-02 1990-07-24 Bioventures, Inc. Simultaneous immunoassay for the determination of antigens and antibodies
SE461570B (sv) * 1988-06-06 1990-03-05 Rama Bio Link Ab Farmaceutiskt preparat och konjugat av en baktericid och en antikropp
WO1990003185A1 (en) * 1988-09-28 1990-04-05 Ideon Corporation Combination enzyme immunotherapeutics
WO1991000112A1 (en) * 1989-06-30 1991-01-10 Brunswick Corporation Antibody-lactate oxidase conjugates

Also Published As

Publication number Publication date
ATE131069T1 (de) 1995-12-15
AU641736B2 (en) 1993-09-30
EP0453097B1 (en) 1995-12-06
AU7299591A (en) 1991-10-03
BR9101117A (pt) 1991-11-05
ES2082132T3 (es) 1996-03-16
JPH05262669A (ja) 1993-10-12
DE69115104D1 (de) 1996-01-18
CA2038578A1 (en) 1991-09-22
IN172885B (https=) 1993-12-25
EP0453097A2 (en) 1991-10-23
JP3098050B2 (ja) 2000-10-10
CA2038578C (en) 2000-11-21
EP0453097A3 (en) 1991-10-30

Similar Documents

Publication Publication Date Title
DE69119817T2 (de) Verwendung von Enzymen
DE3687779T2 (de) Trichotecenkonjugate.
DE69532469T2 (de) Adhäsion inhibierender Vaccinium Extrakt
DE69737532T2 (de) ZUSAMMENSETZUNGEN ZUR KONTROLLE VON ORALEN MIKROBIELLEN OXIDATION-REDUKTION (E h) SPIEGELN
DE69533084T2 (de) Behandlung von antibiotisch-assoziierte-diarrhöe
DE69719834T2 (de) Dentalwerkstoffe enthaltend Cyclodextrine und phenolische Verbindungen
DE69127334T2 (de) Verabreichung von Mitteln
DE69304292T2 (de) Tetracycline inclusive nicht antimicrobiel wirksame, chemisch modifizierte Tetracycline hemmende exzessive Kollagenquervernetzung bei Diabetes
DE3539202C2 (https=)
DE69429369T2 (de) Verfahren und mittel zur behandlung abnormaler zustände des epitheliums von körperöffnungen
DE69615184T2 (de) Fungizid
DE69529288T2 (de) Wasserlösliche polyen-konjugate
DE69115104T2 (de) Composition comprising at least two different antibodies or fragments thereof.
DD204849A5 (de) Verfahren zur herstellung von produkten fuer die behandlung von melanomen
DE3619375A1 (de) Verwendung von alkylglycosiden als potenzierungsmittel in alkohol- oder carbonsaeurehaltigen antiseptischen mitteln sowie alkohol- oder carbonsaeurehaltige desinfektions- und reinigungsmittel mit verstaerkter bakterizider wirkung
DE68901649T2 (de) Verhinderung von zahnplaque durch oberflaechenaktive mittel.
CH619614A5 (https=)
DE69032855T2 (de) Antiidiotypischer antikörper, der eine immunantwort gegen ein glykosphingolipid induziert und seine verwendung
DE69120452T2 (de) Verwendung und Verabreichung von Enzymen
DE69637449T2 (de) Verwendung von alpha-hydroxysäuren zur herstellung eines arzneimittels für die behandlung von entzündungen
DE2541931A1 (de) Immunologische verbindungen
DE2329253A1 (de) Mundpraeparat
DE60216906T2 (de) Anti-pilyrosporum ovale igy und dessen verwendung
DE69219913T2 (de) Ergänzung von Oberflächenrezeptoren
DE68918785T2 (de) Reiningungsmittel für die örtliche Desinfektion.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: QUEST INTERNATIONAL B.V., NAARDEN, NL

8339 Ceased/non-payment of the annual fee